DHAC/Rituximab Regimen

**Semantic type:** Therapeutic or Preventive Procedure

**Definition:** A regimen consisting of carboplatin, cytarabine, dexamethasone and rituximab that can be used for the treatment of diffuse large B-cell lymphoma and mantle cell lymphoma.

**Synonyms:** - Carboplatin-Cytarabine-Dexamethasone -Rituximab - Carboplatin/Cytarabine/Dexamethasone/Rituximab - DHAC Plus Rituximab - DHAC-R - Dexamethasone-Cytarabine-Carboplatin-Rituximab - Dexamethasone/Cytarabine/Carboplatin/Rituximab - Dexamethasone/High-dose Ara-C/Carboplatin/Rituximab - Dexamethasone/High-dose Cytarabine/Carboplatin/Rituximab - R-DHAC - R-DHAC (rituximab-abbs) - R-DHAC (rituximab-arrx) - R-DHAC (rituximab-blit) - R-DHAC (rituximab-pvvr) - R-DHAC (rituximab-rite) - R-DHAC (rituximab-rixa) - R-DHAC (rituximab-rixi)